A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients

Research Site, Beijing

Research Site, Harbin

Research Site, Shanghai

Research Site, Suzhou

Research Site, Tianjin

Research Site, Hangzhou

Research Site, Hangzhou

Research Site, Hangzhou

Research Site, Linhai

Research Site, Hangzhou

Research Site, Wuhan

Research Site, Wuhan

Research Site, Guangzhou

Research Site, Guangzhou

Research Site, Guangzhou

Research Site, Chengdu

Research Site, Jinan

Research Site, Chengde

Research Site, Dingzhou

Research Site, Fuzhou

Research Site, Ganzhou

Research Site, Guangzhou

Research Site, Hangzhou

Research Site, Huanghua

Research Site, Nanchang

Research Site, Weihai

Research Site, Zhuji

Research Site, Shijiazhuang

Research Site, Taiyuan